Physician profile
Daniel Gelvez
NPI 1427635531
$4,291.05
in general payments reported to CMS, 2019-2025
7 companies · $1,247 in 2025
The $1,247 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $718 · 2023: $1,015 · 2024: $1,311 · 2025: $1,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,573.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,676.77 | 2022-2025 | Variax, Gamma, Allowrap |
| Medtronic, INC. | $245.47 | 2024 | Aquamantys(Tm), Cd Horizon Spinal System, Unid_pass |
| Linvatec Corporation | $204.54 | 2024-2025 | Biobrace 23mm |
| Alon Medical Technology | $71.59 | 2025 | |
| Bioventus LLC | $63.25 | 2024-2025 | Exogen Ultrasound Bone Healing System, Bonescalpel & Sonicone (O.R.) |
| Vertex Pharmaceuticals Incorporated | $14.78 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $14.65 | 2024 | Iovera, Zilretta, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gelvez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.